The Project is implemented within the 1.4 POIG program and co-financed by European Regional Development Fund.
The aim of the project is to develop and implement innovative and complex tests for diagnosing genetic predisposition to the most common cancers and genetic diseases, based on DNA microarray technology. The absence on the global market of a test detecting all the key mutations which determine genetic predisposition to the deadliest cancers and genetic diseases is the basis for the project implementation.
The project implementation will result in developing a complex genetic test for detecting and diagnosing key diseases of affluence:
A test for diagnosing predisposition to the seven most common cancers
A test for diagnosing genetic predisposition to diseases of affluence
Above mentioned tests will be of great importance in the prevention and treatment of patients with cancer and diseases of affluence. Early genetic diagnostics and accurate treatment increase the chances of recovery.
Research and development activities are conducted in the DNA Research Center’s Laboratory of Medical Genetics.
Financing agreement number: UDA-POIG.01.04.00-30-082/11-00
Total project costs: 5.298.600,00 PLN
Qualified costs: 5.298.600,00 PLN
Amount of grant: 4.175.005,00 PLN
Project implementation period: 01.07.2012 r.-31.08.2015 r.